Note: This manual went to effect Oct. 1, 2017. It applies to federal agency drug testing programs that come under Executive Order 12564 dated September 15, 1986, section 503 of Public Law 100-71, 5 U.S.C. section 7301 note dated July 11, 1987, and the Department of...
How can we help?
Featured posts
All posts
Instructions to complete the 2020 Federal Drug Testing Custody and Control Form for Urine Specimen Collection
Updated: 3/4/2021 When making entries on a paper CCF, use black or blue ink pen, and press firmly. Collector marks the Urine box above STEP 2. Collector ensures that the name and address of the HHS-certified Instrumented Initial Test Facility (IITF) or HHS-certified...
Guidance for using the 2020 Federal Custody and Control Form for urine specimens
When can a federally regulated program begin using the 2020 Federal CCF? The Office of Management and Budget (OMB) has approved the use of the 2020 Federal CCF as of August 17, 2020. Additional information is available at www.reginfo.gov (enter the OMB number...
2020 Federal Drug Testing Custody and Control Form
The Federal Drug Testing Custody and Control Form is the document used for drug test ordering, specimen collection processing, and chain of custody documentation for workplace drug testing. Get a look at the 2020 form, the most recent version of the form available,...
Search this site
Stay in touch
Give to NDASA
Invest in safe and drug-free communities and workplaces and support NDASA.
Latest News & Updates
- Aug 05, 2022Make Your Voices Heard! Comment on Proposed Amendment to DOT Record-Keeping Regulations
- Jun 08, 2022Where Are We and Where Are We Going? The State of Drug Testing and the Future
- Jun 07, 2022NDASA Responds to SAMHSA Proposed Rules for Oral Fluid Testing in Federal Workplaces
- Jun 07, 2022The Great Retention: How to Hold onto Your Most Valuable Asset, Your Employees
- Jun 07, 2022First-Time Conference Attendee Vows to Return
Topics We Track
- Advocacy (3)
- Business Development (1)
- Committee Reports (1)
- DOT (6)
- Drug & Alcohol Testing (20)
- Drug Legislation (8)
- Feature (51)
- FMCSA (3)
- For Drug Testing Industry Professionals (14)
- For Employers and Workplace Safety & Wellness Professionals (12)
- Industry News (10)
- Marijuana & CBD (13)
- Member Benefits (1)
- Membership (3)
- NDASA Conference (10)
- NDASA Guidance (4)
- Opioids (2)
- Resources (21)
- Substance Use (1)
- Substance Use/Addiction (3)
- Training (1)
- Uncategorized (7)
- Workplace Safety (4)